# Exousia Bio, Inc. (LMMY)

> Consumer Defensive · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/LMMY/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -77.5K | $ -22.40M | $ 0 | $ 21.79M |
| 2024 | $ 12.0K | $ 69.5K | N/A | $ 0 | $ 24.9K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.01 |
| Current Ratio | 0.00 |

## Other views

- [Metrics](https://sponda.capital/en/LMMY.md)
- [Charts](https://sponda.capital/en/LMMY/charts.md)
- [Compare](https://sponda.capital/en/LMMY/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.